Therapeutic Zinc in Childhood Pneumonia
Pneumonia
About this trial
This is an interventional treatment trial for Pneumonia focused on measuring Child, severe pneumonia, Zinc, Nepal, therapeutic
Eligibility Criteria
Inclusion Criteria: Children aged 2- 35 months with a history of cough (duration <14days) and difficult breathing of </= 72hours' duration, with lower chest indrawing. Availability of informed consent. Exclusion Criteria: Children with severe wasting (<70% NCHS median weight for height) Severe anemia (hemoglobin <7 gm/dl.) Presence of heart disease with or without signs of cardiac failure. Child with a chronic cough (lasting for ≥14 days) Documented tuberculosis with ongoing treatment. Associated other severe diseases that require special care or surgical intervention. Children with concomitant diarrhea with some/severe dehydration Children with a history of recurrent wheezing Children enrolled in the study within the last 6 months of this visit
Sites / Locations
- Kanti Children Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Zinc
Placebo
Zinc sulphate 10 or 20 mg per day
Placebo